Who backs Ajax Therapeutics?
11 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| Point72 Ventures | Venture capital |
| Goldman Sachs Asset Management | Other |
| Vivo Capital | Venture capital |
| EcoR1 Capital | Hedge fund |
| Memorial Sloan Kettering Cancer Center | Other |
| Boxer Capital | — |
| Eli Lilly | — |
| Inning One Ventures | — |
| NYU Langone Health | — |
| + 1 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Ajax Therapeutics investors
11 investors are on record for Ajax Therapeutics, including RA Capital Management, Point72 Ventures, Goldman Sachs Asset Management and Vivo Capital. The Series C in May 2024 drew 8 investors.
Free account
More of Ajax Therapeutics with a free account
- ·The complete investor list: 11 names
- ·Watch Ajax Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 11 firms already write checks for companies like Ajax Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View